3PBIOVIAN
Tim Cinq-Mars has significant experience in business development and process engineering within the biopharmaceutical industry. Currently serving as the Head of Business Development at 3PBIOVIAN since January 2024, Tim previously held similar roles at 3P Biopharmaceuticals. With a strong foundation at Amgen, Tim excelled in various engineering roles, focusing on upstream process development and technical project management for biologics. Tim's career also includes early experiences at Genzyme, Biogen Idec, and internships at Amgen and Brown University. Tim holds an MBA in Strategy and Operations from Boston University and a BS in Clinical Laboratory Science/Biotechnology Manufacturing from the University of Rhode Island.
This person is not in any teams
3PBIOVIAN
3PBIOVIAN service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production, with the provision for fill and finish services for recombinant proteins and viral vectors. Leveraging a combined track record of 40 years in process development and analytical methods development, complemented by the experience in process scale-up, GMP manufacturing, and commercial supply, 3PBIOVIAN is equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.